Rehmann Capital Advisory Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-12
| Closed | -$320 | – | 1690 |
|
|
2019
Q2 | $320 | Sell |
12
-68
| -85% | -$1.81K | ﹤0.01% | 2011 |
|
|
2019
Q1 | $2.15K | Sell |
80
-405
| -84% | -$10.9K | ﹤0.01% | 1746 |
|
|
2018
Q4 | $7.84K | Buy |
485
+417
| +613% | +$6.74K | ﹤0.01% | 1129 |
|
|
2018
Q3 | $1.41K | Sell |
68
-238
| -78% | -$4.94K | ﹤0.01% | 1899 |
|
|
2018
Q2 | $4.67K | Sell |
306
-323
| -51% | -$4.93K | ﹤0.01% | 1559 |
|
|
2018
Q1 | $14K | Buy |
+629
| New | +$14K | ﹤0.01% | 1186 |
|